entete

Photos of our research Group

Pulmonary Vascular Research Institute congress, 2019

The 13th annual congress of Pulmonary Vascular Research Institute took place from January 30th to February 3rd 2019 in Barcelona, Spain. Some members of the research group presented their research project and share their knowledge in Pulmonary Hypertension pathogenesis with other researchers. 

During this congress, some team members and ex-member received distinction and awards. Our fellowship trainee Junichi Omura received a Presentation award in category Fellow for his project on lncH19; Dr Roxane Paulin received a Travel award and a Presentation award in young investigator category; Dr Olivier received the Abstract/Poster young investigator; Finally Drs Sébastien Bonnet and Steeve Provencher were honored with a recognition award of scientific program chair.

We want also to emphasize that Dr François Potus, alumni of our research group, received the Rupert Swift award, a newly established PVRI Grant to support a young, promising researcher in pulmonary vascular diseases field. 

Congratulations!

American Heart Association congress, 2018

American heart Association congress took place from November 10-12th 2018, Chicago (IL). Some members of the research group presented their research project and share their knowledge on Pulmonary Hypertension field with other international researchers.

After getting Cardiopulmonary best abstract Award from AHA 3CPR Council, Dr Junichi Omura obtained one of the famous AHA' famous price, the 2018 Paul Dudley White International Scholar. This price recognizes the Authors with the highest rank abstract from all Canada' submissions at scientific sessions 2018. This congress is the largest meeting of cardiovascular experts in the world, involving tens of thousands of people every year. 

We would also like to emphasize that Karima Habbout and Alice Bourgeois, students under supervision of Dr Boucherat, received a Travel Award to present their research project in this congress. 

In addition to these good news, our research group participated in obtaining the abstract of Netherlands submitted to AHA. Indeed, our research group with Netherlands' PH consortium, demonstrated that BRD4 protein inhibition improves PAH. This work, initiated by Dre Meloche (alumni), was deepened by Eve Tremblay (research assistant) an by our colleagues from Netherlands. All of this work has led to the setting up of a clinical trial at IUCPQ under direction of Drs Provencher and Bonnet.

 

À pleins poumons pour l'HTAP! 2018 Edition

October 14th 2018 took place the third edition of the challenge ''À pleins poumons pour l'HTAP!'', where 11 members of Pulmonary arterial research Group have been challenged to a running of 10 or 21 km during the SSQ Québec marathon to support advance in PAH research.

Thanks to  the support of population and different partners. With IUCPQ Foundation partnership, this fund raising will allow to come in assistance to people present sick and those will be in the future. Amassed funds will be used to advance the search in order to develop the therapies of the future and to offer cutting edge care to patients suffering from PAH.

European Respiratory Society congress, 2018

European Respiratory Society congress took place from September 15th-19th 2018, Paris (France).

Some members of the research group presented their research project and share their knowledge on Pulmonary Hypertension field with other international researchers.

 

In addition, some alumni of the research group shared some time together to... feast!

American Thoracic Society congress, 2018

American Thoracic Society congress took place from May 18th-23rd 2018, San Diego (CA).

Some members of the research group presented their research project and share their knowledge on Pulmonary Hypertension field with other international researchers.

In addition, members gathered took the opportunity to realize a 10km race in order to realize their personal challenge to '' À plein poumon pour l'HTAP!'', that will take place in October 2018.

 

American Heart Association congress, 2017

American Heart Association congress took place from November 11th-14th 2017, Anaheim (CA).

Some members of the research group presented their research project and share their knowledge on Pulmonary Hypertension field.

À pleins poumons!, 2017 edition

August 27th 2017 has taken place the second edition of the challenge'' À pleins poumons pour l'HTAP!'', where 20 members of Pulmonary arterial research group were challenged to support the people affected by this grave disease. A running of 10km or 21km has been done during SSQ Levis marathon to raise awareness and make sensitive the population to this disease.

With the support of population and different partners especially Bayer Canada, we are proud to announce that we collected 9000$. With IUCPQ Foundation partnership, this fund raising will allow to come in assistance to people present sick and those will be in the future. Amassed funds will be used to advance the search in order to develop the therapies of the future and to offer cutting edge care to patients suffering from PAH.

 

VWR's customer appreciation evening

A VWR's customer appreciation evening has been taken June 12th 2017 on Louis-Jolliet boat with supper and dance evening. 

À pleins poumons pour l'HTAP!, 2017 edition

The CHALLENGE

August 27th 2017 will be place the second edition of the challenge ''À pleins poumons pour l'HTAP!'', where 20 members of Pulmonary arterial research Group wil be challenged to a running of 10 or 21 km during the SSQ Levis marathon to support advance in PAH research.  

Funding

Last May, some members of the research Group had been done fresh herbs sale to IUCPQ cafeteria and benefits went to Pulmonary Hypertension Research Group from IUCPQ Foundation. Thank you for your collaboration!

À pleins poumons pour l'HTAP!, 2016 edition

The CHALLENGE

Auguste 28th 2016 has taken place the first edition of the challenge'' À pleins poumons pour l'HTAP!'', where 17 members of Pulmonary arterial research group were challenged to support the people affected by this grave disease. A running of 10km has been done during SSQ Levis marathon to raise awareness and make sensitive the population to this disease.

OBJECTIVE: 10 000$

With the support of population and different partners especially Bayer Canada, we are proud to announce that we collected 7044$. With IUCPQ Foundation partnership, this fund raising will allow to come in assistance to people present sick and those will be in the future. Amassed funds will be used to advance the search in order to develop the therapies of the future and to offer cutting edge care to patients suffering from PAH.

© 2012 Université Laval. Tous droits réservés